Chan‐Young Ock

Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer

Sehhoon Park, Chan‐Young Ock, Hyojin Kim et al. · Journal of Clinical Oncology · 2022 · 282 citations · Full text

Medicine, Immunology, Oncology +17

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With <i>EGFR</i>- or <i>ALK</i>-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

Sehhoon Park, Tae Min Kim, Ji‐Youn Han et al. · Journal of Clinical Oncology · 2023 · 164 citations · Full text

Medicine, Oncology, Pharmacology +17

Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer

Sehui Kim, Ji-Young Jang, Jaemoon Koh et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 103 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma

Changhee Park, Kwon Joong Na, Hongyoon Choi et al. · Theranostics · 2020 · 90 citations · Full text

Medicine, Immunology, Oncology +17

Association of PD-L1 Expression with Tumor-Infiltrating Immune Cells and Mutation Burden in High-Grade Neuroendocrine Carcinoma of the Lung

Hye Sook Kim, Jeong Hyeon Lee, Soo Jeong Nam et al. · Journal of Thoracic Oncology · 2018 · 82 citations · Full text

Medicine, Cancer Biology, Oncology +15